Ligand Pharmaceuticals (LGND) Competitor Comparison
We are evaluating the key criteria listed to compare Ligand Pharmaceuticals (LGND) against its competitors in the Biotechnology industry.
Market Capitalization
96 / 368Gross Profits
44 / 278Total Revenue
73 / 300EBITDA
24 / 337Free Cashflow
19 / 352Quick Ratio
46 / 357Earnings per Share
11 / 359Dividend yield
0 / 6Total Cash
162 / 358Performance 3 years
125 / 368Performance 5 years
124 / 368Performance 10 years
59 / 368Linearity 3 years
65 / 368Linearity 5 years
36 / 368Linearity 10 years
146 / 368Total Rank
180 / 368Dividend Rank
42 / 368Valuation Rank
213 / 368Piotroski Rank
144 / 368Muliplier Rank
140 / 368Market Capitalization - LGND ranking 96 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.